Quick Answer: MoCRA requires the responsible person to ensure, and maintain records supporting, adequate safety substantiation for each cosmetic product. FDA does not prescribe one universal test battery. The evidence should be scientifically robust, relevant to the product and its intended use, and maintained before the product is marketed in the United States.
What is cosmetic safety substantiation under MoCRA?
Safety substantiation is the body of records that supports a reasonable conclusion that a cosmetic product is safe under its labelled or customary conditions of use. Under MoCRA, the responsible person must ensure and maintain these records. FDA’s MoCRA overview is the primary official starting point for the requirement.
This is not the same as an FDA pre-market approval file. Cosmetics generally are not pre-approved by FDA, and a safety file does not convert a cosmetic into an approved product. Product classification, claims and ingredients still need their own assessment.
Who is responsible for the safety substantiation record?
The responsible person is the manufacturer, packer or distributor whose name appears on the label. A contract manufacturer can generate, retain and supply technical evidence, but the manufacturer’s role does not automatically displace the responsible person’s legal duty. Agreements should clearly describe document ownership, change notification and access to records.
| Party | Core responsibility | Evidence or action |
|---|---|---|
| Responsible person | Ensure and maintain adequate safety substantiation records. | Safety rationale, final formula and label review, supplier evidence, decisions and updates. |
| OEM/ODM manufacturer | Provide accurate technical and production information supporting the assessment. | INCI list, specifications, batch records, stability information, microbiological information where appropriate and packaging-compatibility data. |
| Ingredient supplier | Support material identification and relevant technical data. | Specifications, certificates, safety data and change notifications as applicable. |
| Brand / importer team | Protect the market-facing record and keep claims, labels and incidents aligned. | Final artwork, complaints process, adverse-event escalation and market change log. |
What evidence can support a cosmetic safety conclusion?
There is no one-size-fits-all file. The appropriate evidence depends on the formula, route of exposure, intended users, packaging and use conditions. FDA has stated that the law does not require a specific kind of testing for cosmetics. A responsible person should use scientifically sound evidence that fits the product rather than treating any single document as a universal pass certificate.
| Step | Purpose | Example records to organize |
|---|---|---|
| 1. Confirm product status and intended use | Check that the product is being evaluated as a cosmetic and that claims match its intended use. | Product brief, target user, directions, warning statements and claim review. |
| 2. Freeze the formula and packaging inputs | Assess the product actually intended for market. | Formula version, INCI list, raw-material specifications, packaging specifications. |
| 3. Assess relevant safety evidence | Build a product-specific scientific rationale. | Ingredient data, exposure considerations, stability information, microbiological controls where appropriate and compatibility findings. |
| 4. Document the conclusion | Show how the available evidence supports safe use under labelled conditions. | Safety assessment record, limitations, unresolved questions and approval trail. |
| 5. Maintain and update | Keep the record aligned with the marketed product. | Formula change log, supplier changes, complaints, adverse-event records and revised labels. |
When should the safety file be reviewed?
Review is a lifecycle discipline, not only a launch task. A new fragrance, preservative, packaging material, claim, target user group or manufacturing change can affect the basis for the existing conclusion. The responsible person should define change-control triggers and make sure the manufacturer communicates relevant changes before production resumes.
| Product moment | Safety-substantiation check | Why it matters |
|---|---|---|
| Concept and claim development | Screen intended use and claims for cosmetic status and potential risk questions. | Claims can change regulatory classification and the evidence needed. |
| Formula finalization | Lock formula version and collect supplier / technical evidence. | A file built on an obsolete formula is not reliable support for the marketed product. |
| Packaging approval | Consider compatibility and labelled use conditions. | Container interaction and dispensing can affect the finished product. |
| Pre-launch | Record the product-specific conclusion and unresolved controls. | The responsible person should be able to produce the substantiation record when required. |
| Post-market and changes | Review complaints, serious adverse events and material changes. | New information can require a refreshed safety conclusion or corrective action. |
What MoCRA does not require
- It does not create a single FDA-approved “safety certificate” for a cosmetic.
- It does not prescribe one mandatory list of laboratory tests for every product.
- It does not make a contract manufacturer automatically responsible person for every private-label product.
- It does not remove the need to assess labelling, claims, records, registration/listing and post-market duties separately.
Common gaps in private-label safety documentation
- Keeping only a COA and treating it as the complete safety rationale.
- Using an INCI list that does not match the released formula revision.
- Not documenting the final intended use, warnings or target user group.
- Failing to obtain prompt supplier-change notifications.
- Separating brand complaints from the team that holds technical records.
What can a cosmetic manufacturer provide?
MOOYAM can provide technical documentation that helps an international brand organize its assessment: formula and INCI information, manufacturing records, COA, SDS where applicable, stability information, microbiological reports where appropriate, packaging-compatibility information and batch documentation. The responsible person should decide how that information supports the final product-specific safety substantiation and retain the resulting record.
MOOYAM provides cosmetic OEM/ODM manufacturing and technical documentation support for international beauty brands. Contact our team to discuss the documentation needed for your product and target market.
FAQ
Is a CPSR the same as MoCRA safety substantiation?
No. A CPSR is an EU documentation concept. It may be useful evidence in a broader dossier, but the U.S. responsible person must still assess current MoCRA requirements for the product marketed in the United States.
Does MoCRA require animal testing?
FDA says the law does not require any specific type of testing for cosmetics. A safety approach should use scientifically sound evidence appropriate to the product and comply with all applicable rules.
Can a manufacturer prepare the safety records?
A manufacturer can supply technical information and help organize records. The responsible person remains responsible for ensuring and maintaining adequate safety substantiation.
When should the safety record be updated?
Update it when changes could affect the product’s safety conclusion, such as formula, packaging, use conditions, target users, supplier information or relevant post-market information.
Does a product listing prove safety substantiation?
No. Product listing and safety substantiation are separate MoCRA obligations; a listing is not an approval or substitute for supporting records.
Official sources
- FDA: Modernization of Cosmetics Regulation Act of 2022 (MoCRA)
- FDA: Cosmetics and U.S. law
- FDA: Small businesses and homemade cosmetics fact sheet
- FDA: Cosmetic labeling guide
Last reviewed: September 17, 2026
Regulatory requirements may change. Brands should verify current requirements with the relevant regulatory authority or qualified compliance professional before placing cosmetic products on the market.